Po Chor Tam

Queen Mary Hospital

Papers

1

Total Citations

8

H-Index

1

About

Po Chor Tam is a leading urological oncologist whose work has been instrumental in shaping prostate cancer care, particularly during global health crises. His research focuses on the intersection of urological oncology, clinical management strategies, and health system resilience. Tam is best known for his pivotal contributions to the development of evidence-based guidelines for prostate cancer management during the COVID-19 pandemic, as exemplified by his highly cited 2021 paper, "Prostate cancer management in the era of COVID‐19: Recommendations from the Hong Kong Urological Association and Hong Kong Society of Uro‐oncology." This work, which has garnered 8 citations, provided critical, interdisciplinary recommendations for prioritizing and adapting treatment across all stages of prostate cancer, ensuring continuity of care amid unprecedented healthcare disruptions. His contributions have directly influenced clinical protocols in Hong Kong and beyond, demonstrating a commitment to translating real-world challenges into actionable solutions. Tam’s expertise in navigating complex clinical scenarios underscores his role as a key voice in modern urological oncology, where his work continues to guide practitioners in delivering safe, effective patient care under pressure.

Research Focus

Key Achievements

1
H-Index
1
Papers
8
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Prostate cancer management in the era of COVID‐19: Recommendations from the Hong Kong Urological Association and Hong Kong Society of Uro‐oncology
8 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Queen Mary Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago